VIT and Genotypic Technology seal the pact
Talking exclusively to BioSpectrum India, Dr Sudha Rao, co-founder and executive director, Genotypic Technology said, "Having a separate R&D unit developing products and retention of youngsters was important as most of them were master's degree graduates who were leaving for higher studies to acquire skills in Genomic technology. Hence, we considered it a good strategy to retain young talents and as well as to support our R&D programs."VIT has proactively initiated PhD programs in the area of Genomic research. "We were looking at various universities, but there was a lot of bureaucracy. We want to collaborate complimenting our strengths," Dr Sudha added.
Dr Venkatesh Krishnamurthy, research director, Genotypic Technology, expressed that by collaborating and sharing resources and infrastructure, they can complement each other by working together. "As a company we do not have access to certain samples, and this understanding is a simple way of collaborating," he said.
Talking about the terms of the MoU, Dr Sudha Rao added, "It was more to do with relationship building. VIT is growing as a university. They need experts like us to be a part of their workshops and programs and take in students for training and knowledge transfer."
Dr Raja C Mugasimangalam, CEO and founder, Genotypic Technology, said, "We are very pleased and happy to work with a reputed institution like VIT. We look forward to apply cutting-edge Genomic tools to develop intellectual properties and key research publications."
Dr Sudha Rao believes that there is a huge gap between academia and industry. "This MoU will try to fill the gap, where it gets the industry close to academics and vice versa. It is the right mix which can lead to good product developments and publications. Also, there are many ways to utilize what VIT has in to our R&D and products.